SciSparc to seek US FDA nod to begin phase IIb trial with SCI-110 to treat Tourette syndrome: Tel Aviv, Israel Monday, July 11, 2022, 16:00 Hrs [IST] SciSparc Ltd., a specialty cl ...
A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use by the NHS for the first time. The technology, known as ORBIT (Online ...
The directors of Asarina Pharma have abandoned a search for a partner for Tourette's syndrome treatment sepranolone, saying they have no choice but to liquidate the company. Just over a year ago, the ...
2700 Through his Word, God speaks to man. By words, mental or vocal, our prayer takes flesh. Yet it is most important that the heart should be present to him to whom we are speaking in prayer: ...
The following guide offers a detailed overview of several classes of medications that research links to a higher risk of dementia. You will find what these drugs treat, the evidence connecting them to ...